Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
HealiRNA is a ribonucleic acid drug research and development company.
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Power Site is a modern technology enterprise that supplies X-ray imaging core components.
Minimax Medical Holding Group is a medical science and technology group.
RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.
Mebias Discovery holds a game-changing platform to discover next generation.
Tridek-One is a biopharmaceutical company aiming to develop immunomodulatory compounds targeting the CD31 pathway.
JoyMed Technology is a designer and manufacturer of medical devices.
Redbud Medicine is an international leading CRO and drug regulatory company.
Regenacy Pharmaceuticals Provides Healthcare Services.
Palline is a hospital management solution and operational data analysis company.
Dami&Xiaomi is a child autism intervention agency.
Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
Ehomepoct is an artificial intelligence disease management company.
Tetris Therapeutics is a platform-based biotechnology company
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
Resproly is a respiratory system inhalation therapy and device developer.
Pathware is creating hardware and software to simplify digital pathology workflows.
BioVenture has invested in 273 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Biopharma. The firm invests across 25 different industry categories.
Among tracked funding rounds, Dami&Xiaomi received $42.0M in a Series D round. BioVenture's total known invested capital is $1.3B.
BioVenture's average investment size is $25.0M across its portfolio of 273 companies.
Recent BioVenture portfolio additions include Cullgen, Araris Biotech, Boaoxin, Teitur Trophics, Su Hui therapy. These companies were founded in 2020 or later.